Sumant Ramachandra is the founder of ImmPACT Bio USA. ImmPACT Bio USA has raised $129M in total funding. Latest round: Series B. Based in Camarillo, CA.
Sumant Ramachandra is an M.D., Ph.D. who served as the CEO of ImmPACT Bio USA, a clinical-stage biopharmaceutical company. He led the company through its $18 million Series A round in 2020 and was CEO when the company announced a $111 million Series B round in January 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library